Table 2.
Methodological design choices and assumption parameters in injury burden of disease studies
| Author | Year | Single- or multi-country category? | Geographic Location | Type of study | Injury classification | Classification of injury diagnosis | Design choices of YLL calculations | Design choices of YLD calculations | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Independent study | GBD-linked study | Cause-of-injury category | Nature-of-injury category | Incidence- or prevalence-based approach? | Usage of disability weights | ||||||
| Aldridge et al. [50] | 2017 | Multi-country | WHO European Region | • | • | ICD-9; ICD-10 | WHO standard model life tables | Prevalence | GBD DWs | ||
| Begg & Tomijima [60] | 2006 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | ||
| Crowe et al. [52] | 2020 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | NA | Prevalence | GBD DWs | |
| Dhondt et al. [23] | 2012 | Single-country | Belgium (Flanders; Brussels) | • | • | • |
ICD-9 (aggregated to the EUROCOST classification) |
Belgian life table | Incidence | Empirical DWs; GBD DWs | |
| Dhondt et al. [22] | 2013 | Single-country | Belgium (Flanders; Brussels) | • | • | • | ICD-9; ICD-10 (aggregated to the EUROCOST classification) | Belgian LE | Incidence | Dutch DWs; GBD DWs | |
| Fattahov & Piankova [64] | 2018 | Single-country | Russia | • | • | ICD-10 | GBD standard model life tables | NA | NA | ||
| Franklin et al. [65] | 2020 | Multi-country | Global | • | ICD-9; ICD-10 | GBD standard model life tables | NA | NA | |||
| Gobbino et al. (on behalf of CRMSS) [24] | 2012 | Single-country | Italy (Friuli Venezia Giulia) | • | • | • | ICD-9 | Italian life table | Incidence | Australian DWs | |
| Haagsma et al. [25] | 2008 | Single-country | Netherlands | • | • |
ICD-9 (aggregated to the EUROCOST classification) |
NA | Incidence | Empirical DWs | ||
| Haagsma et al. [43] | 2012 | Multi-country | Netherlands; Ceres; Thailand | • | • | ICD-10 (aggregated to the EUROCOST classification) | Standard West 26 | Incidence | Empirical DWs | ||
| Haagsma et al. [1] | 2016 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | |
| Haagsma et al. [54] | 2020 | Multi-country | GBD Western Europe | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
| Haagsma et al. [53] | 2020 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
| Hagen et al. [26] | 2020 | Single-country | Norway | • | • | NR | GBD standard model life tables | Incidence | GBD DWs | ||
| Hoeymans & Schoemaker [38] | 2010 | Single-country | Netherlands | • | • | • | ICD-10 | Dutch life table | Incidence | Empirical DWs | |
| Holtslag et al. [27] | 2008 | Single-country | Netherlands | • | • | NR | Dutch life table | Incidence | Empirical DWs | ||
| James et al. [55] | 2019 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | |
| James et al. [11] | 2019 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | NA | Prevalence | GBD DWs | |
| James et al. [56] | 2020 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | NA | Prevalence | GBD DWs | |
| Johnell & Kanis [44] | 2004 | Multi-country | World Bank Regions | • | • | NR | NR | Incidence | GBD DWs | ||
| Khan et al. [57] | 2020 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
| Lalloo et al. [58] | 2020 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | |
| Lapostolle et al. [28] | 2009 | Single-country | France | • | • | • | ICD-10 (AIS codes) | French LE | Incidence | GBD DWs | |
| Leliveld et al. [29] | 2020 | Single-country | Netherlands | • | • | ICD-9; ICD-10 | NA | Incidence | Empirical DWs | ||
| Lin [59] | 2016 | Multi-country | Global | • | • | NR | GBD standard model life tables | Prevalence | GBD DWs | ||
| Lukaschek et al. [66] | 2012 | Single-country | Germany | • | • | ICD-10 | German LE | NA | NA | ||
| Lunevicius & Haagsma [41] | 2018 | Single-country | England (9 English Regions) | • | • | ICD-9; ICD-10 | GBD standard model life tables | Prevalence | GBD DWs | ||
| Lyons et al. [45] | 2017 | Multi-country | EU-28 | • | • | • | ICD-10 | GBD standard model life tables | Incidence | Empirical DWs | |
| Majdan et al. [67] | 2017 | Multi-country | EU-16 | • | • | • | ICD-10 | European Union life table | NA | NA | |
| Naghavi et al. [68] | 2019 | Multi-country | Global | • | • | ICD-9; ICD-10 | GBD standard model life tables | NA | NA | ||
| NHS Health Scotland [39] | 2016 | Single-country | Scotland | • | • | • | ICD-10 | Scottish life table | Prevalence | GBD DWs | |
| NHS Health Scotland [40] | 2016 | Single-country | Scotland | • | • | • | ICD-10 | Scottish life table | Prevalence | GBD DWs | |
| Peden et al. [61] | 2002 | Multi-country | Global | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | |
| Polinder et al. [47] | 2007 | Multi-country | Austria; Denmark; UK (England & Wales); Ireland; Norway; Netherlands | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | |
| Polinder et al. [46] | 2010 | Multi-country | Austria; Latvia; Denmark; UK (England & Wales); Ireland; Netherlands; Norway; Slovenia | • | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs; Empirical DWs | |
| Polinder et al. [31] | 2012 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | GBD standard model life tables | Incidence | Empirical DWs | ||
| Polinder et al. [30] | 2015 | Single-country | Netherlands | • | • | ICD-9 (MAIS code; aggregated to the EUROCOST classification) | GBD standard model life tables | Incidence | Empirical DWs | ||
| Prins et al. [32] | 2021 | Single-country | Netherlands | • | • | NA | NA | Incidence | Empirical DWs | ||
| Scholten et al. [33] | 2014 | Single-country | Netherlands | • | • | ICD-9 | GBD standard model life tables | Incidence | Empirical DWs | ||
| Snijders et al. [34] | 2016 | Single-country | Netherlands | • | • | • | ICD-9 | Dutch life table | Incidence | Empirical DWs | |
| Sethi et al. [62] | 2008 | Multi-country | WHO European Region | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | ||
| Spronk et al. [48] | 2020 | Multi-country | Netherlands; New Zealand; Australia | • | • | NA | NA | Incidence | Empirical DWs | ||
| Tainio et al. [35] | 2014 | Single-country | Sweden | • | • | • | ICD-9; ICD-10 (AIS code) | GBD standard model life tables | Incidence | GBD DWs | |
| Tainio [42] | 2015 | Single-country | Poland | • | • | NR | NR | Polish data on traffic fatalities and GBD 2010 data | NR | ||
| Twisk et al. [36] | 2017 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | Dutch LE | Incidence | Empirical DWs | ||
| Valent et al. [63] | 2004 | Multi-country | WHO European Region | • | • | ICD-9; ICD-10 | GBD standard model life tables | Incidence | GBD DWs | ||
| Weijermars et al. [37] | 2016 | Single-country | Netherlands | • | • | ICD-9 (aggregated to the EUROCOST classification) | NA | Incidence | Empirical DWs | ||
| Weijermarset al. [49] | 2018 | Multi-country | Austria; Spain; Belgium; France; England; Netherlands | • | • | • | ICD-9; ICD-10; aggregated to the EUROCOST classification) | NA | Incidence | Empirical DWs | |
AIS Abbreviated Injury Scale, BoD Burden of Disease, CRMSS Centro regionale di monitoraggio della sicurezza stradale, DALY Disability-Adjusted Life Years, DW Disability Weight, EUROCOST EUROCOST classification of injuries, GBD Global Burden of Disease, ICD International Classification of Diseases, LE Life Expectancy, MAIS Maximum Abbreviated Injury Scale, NA Not Applicable, NR Not Reported, UK United Kingdom, YLD Years-Lived with Disability, YLL Years of Life Lost due to premature mortality, WHO World Health Organization